by claudia la via In 2024, the Swiss M&A landscape is predicted to see a robust recovery, marking a stark contrast from the cautious approach witnessed in 2023. As companies align with more stable economic conditions, there’s a palpable shift toward seizing strategic opportunities. This is what PwC Switzerland reports in its Swiss M&A Trend […]
by claudia la via When the financial support measures taken by the Swiss Federal Council to support businesses suffering from the effect of the coronavirus pandemic came to an end in 2022, the number of bankruptcies
PQ, a global producer of silicates, silicas and derivate products and headquartered in the US, has acquired the specialty silicate business of Swiss-based vanBaerle Group. The Swiss group is a leading manufacturer of high-grade silicates,
Niederer Kraft Frey advised Transgourmet Switzerland, the second biggest wholesaler in Europe, on the acquisition of POMONA SUISSE. With this acquisition, the company is strengthening its expertise in innovative product ranges as well as in
Fahrzeug-Werke LUEG, one of the largest mobility providers in Germany and a renowned sales and service partner of the Daimler group, has acquired the Mercedes-Benz dealership Elite Autocenter in Wilderswil near Interlaken, in the canton
The Swiss FinTech Start-Up LEND has successfully completed a Series C financing round of CHF 2,5 million. In the course of the financing round, crowd investors have been issued new shares in the form of ledger-based
Altenburger advised Kylian Mbappé in a long-term strategic partnership with Loewe. Soccer superstar will be the worldwide brand ambassador of the brand, a global player in the luxury segment of the consumer electronics industry. Mbappé
Proteomedix, a Swiss private, commercial-stage diagnostics oncology company and Water Biotech are forming together a company called Onconetix. The transaction is implemented by the acquisition of Proteomedix for an all stock consideration. Onconetix’s commercial
Leonteq, a Swiss fintech company, received advisory support from Niederer Kraft Frey in its acquisition of a 10% stake in the Swiss stock exchange BX Swis, which is an established stock exchange based in Zurich whose
Schellenberg Wittmer advised Bioventure Club Deal Nine & Co KG in a Series C financing round of the Swiss Aphaia companies, which are clinical-stage pharmaceutical companies that have developed proprietary treatment methods targeting obesity and
